Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Widefield Imaging Devices Market: By Modality, By End User, By Indication, and Region Forecast 2019-2030
Widefield Imaging Devices Market size was valued at US$ 548.5 million in 2023 and is poised to grow at a significant CAGR of 8.4% from 2024-2030. Upgrades in telemedicine and portable camera technology have made these devices easier to use and more accessible, and other new breakthroughs are expected to grow the market for wide-field imaging devices. Widefield imaging techniques may have a substantial impact on patient care in the future, but more study is needed to establish the clinical importance of peripheral data and to solve widefield imaging's optical flaws.
Nonetheless, this fascinating technology has attracted people's interest. As the area of retinal imaging advances, understanding of ocular disease processes improves. Newer technologies, which address the need of ophthalmologists towards achieving the proper diagnosis and appropriate management of disease entities, have helped improve patient care and management ultimately in our current ophthalmic practice.
Study Period
2024-2030Base Year
2023CAGR
8.4%Largest Market
North AmericaFastest Growing Market
North America
Diabetic retinopathy is becoming more common, as diabetes is the major cause of new occurrences of blindness in people. As the number of people living with diabetes rises, so does the number of people who suffer from vision impairment. According to a recent study done by the CDC, diabetic retinopathy affects over one-third of persons over the age of 40 who have diabetes, and more than one-third of African Americans and Mexican Americans. Over the forecast period, the worldwide widefield imaging systems market is expected to rise due to the rising prevalence of diabetic retinopathy. However, the company's growth may be hampered by a stringent regulatory framework and hefty gadget costs.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 548.5 million |
Market CAGR |
8.4% |
By Modality |
|
By Indication |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
Widefield imaging devices market size was valued at US$ 548.5 million in 2023 and is set to grow at a significant CAGR of 8.4% from 2024-2030.
Clarity Medical Systems, Inc., Epipole Ltd., Forus Health Pvt Ltd, Heidelberg Engineering Inc.
Asia-Pacific is the fastest-growing region for Widefield Imaging Devices Market
1.Executive Summary |
2.Global Widefield Imaging Devices Market Introduction |
2.1.Global Widefield Imaging Devices Market - Taxonomy |
2.2.Global Widefield Imaging Devices Market - Definitions |
2.2.1. By Modality |
2.2.2. By Indication |
2.2.3. By Application |
2.2.4. By End-User |
2.2.5.Region |
3.Global Widefield Imaging Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Widefield Imaging Devices Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Widefield Imaging Devices Market By Modality, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Portable |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Standalone |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Widefield Imaging Devices Market By Indication, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Uveitis |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Retinopathy of Prematurity |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Retinal Vein Occlusion |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Pediatric Retinal Diseases |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Ocular Oncology |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Glaucoma |
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Diabetic Retinopathy |
6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Chorioretinal Diseases |
6.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
6.9. Others |
6.9.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.9.3. Market Opportunity Analysis |
7.Global Widefield Imaging Devices Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Glaucoma |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diabetic retinopathy |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Age- Related Macular Degeneration |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Central Serous Retinopathy |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Vitreous Traction |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Pediatric |
7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Point of Care |
7.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
7.8. Others |
7.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.8.3. Market Opportunity Analysis |
8.Global Widefield Imaging Devices Market By End-User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Ambulatory Surgical Centers |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Hospitals |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Specialty Clinics |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Widefield Imaging Devices Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Widefield Imaging Devices Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Modality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Portable |
10.1.2.Standalone |
10.2. Indication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Uveitis |
10.2.2.Retinopathy of Prematurity |
10.2.3.Retinal Vein Occlusion |
10.2.4.Pediatric Retinal Diseases |
10.2.5.Ocular Oncology |
10.2.6.Glaucoma |
10.2.7.Diabetic Retinopathy |
10.2.8.Chorioretinal Diseases |
10.2.9.Others |
10.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Glaucoma |
10.3.2.Diabetic retinopathy |
10.3.3.Age- Related Macular Degeneration |
10.3.4.Central Serous Retinopathy |
10.3.5.Vitreous Traction |
10.3.6.Pediatric |
10.3.7.Point of Care |
10.3.8.Others |
10.4. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Ambulatory Surgical Centers |
10.4.2.Hospitals |
10.4.3.Specialty Clinics |
10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Widefield Imaging Devices Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Portable |
11.1.2.Standalone |
11.2. Indication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Uveitis |
11.2.2.Retinopathy of Prematurity |
11.2.3.Retinal Vein Occlusion |
11.2.4.Pediatric Retinal Diseases |
11.2.5.Ocular Oncology |
11.2.6.Glaucoma |
11.2.7.Diabetic Retinopathy |
11.2.8.Chorioretinal Diseases |
11.2.9.Others |
11.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Glaucoma |
11.3.2.Diabetic retinopathy |
11.3.3.Age- Related Macular Degeneration |
11.3.4.Central Serous Retinopathy |
11.3.5.Vitreous Traction |
11.3.6.Pediatric |
11.3.7.Point of Care |
11.3.8.Others |
11.4. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Ambulatory Surgical Centers |
11.4.2.Hospitals |
11.4.3.Specialty Clinics |
11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Widefield Imaging Devices Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Portable |
12.1.2.Standalone |
12.2. Indication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Uveitis |
12.2.2.Retinopathy of Prematurity |
12.2.3.Retinal Vein Occlusion |
12.2.4.Pediatric Retinal Diseases |
12.2.5.Ocular Oncology |
12.2.6.Glaucoma |
12.2.7.Diabetic Retinopathy |
12.2.8.Chorioretinal Diseases |
12.2.9.Others |
12.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Glaucoma |
12.3.2.Diabetic retinopathy |
12.3.3.Age- Related Macular Degeneration |
12.3.4.Central Serous Retinopathy |
12.3.5.Vitreous Traction |
12.3.6.Pediatric |
12.3.7.Point of Care |
12.3.8.Others |
12.4. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Ambulatory Surgical Centers |
12.4.2.Hospitals |
12.4.3.Specialty Clinics |
12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Widefield Imaging Devices Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Portable |
13.1.2.Standalone |
13.2. Indication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Uveitis |
13.2.2.Retinopathy of Prematurity |
13.2.3.Retinal Vein Occlusion |
13.2.4.Pediatric Retinal Diseases |
13.2.5.Ocular Oncology |
13.2.6.Glaucoma |
13.2.7.Diabetic Retinopathy |
13.2.8.Chorioretinal Diseases |
13.2.9.Others |
13.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Glaucoma |
13.3.2.Diabetic retinopathy |
13.3.3.Age- Related Macular Degeneration |
13.3.4.Central Serous Retinopathy |
13.3.5.Vitreous Traction |
13.3.6.Pediatric |
13.3.7.Point of Care |
13.3.8.Others |
13.4. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Ambulatory Surgical Centers |
13.4.2.Hospitals |
13.4.3.Specialty Clinics |
13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Widefield Imaging Devices Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
14.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Portable |
14.1.2.Standalone |
14.2. Indication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Uveitis |
14.2.2.Retinopathy of Prematurity |
14.2.3.Retinal Vein Occlusion |
14.2.4.Pediatric Retinal Diseases |
14.2.5.Ocular Oncology |
14.2.6.Glaucoma |
14.2.7.Diabetic Retinopathy |
14.2.8.Chorioretinal Diseases |
14.2.9.Others |
14.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Glaucoma |
14.3.2.Diabetic retinopathy |
14.3.3.Age- Related Macular Degeneration |
14.3.4.Central Serous Retinopathy |
14.3.5.Vitreous Traction |
14.3.6.Pediatric |
14.3.7.Point of Care |
14.3.8.Others |
14.4. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Ambulatory Surgical Centers |
14.4.2.Hospitals |
14.4.3.Specialty Clinics |
14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Carl Zeiss Meditec AG |
15.2.2.CENTERVUE S.P.A. |
15.2.3.Clarity Medical Systems, Inc. |
15.2.4.Epipole Ltd. |
15.2.5.Forus Health Pvt Ltd |
15.2.6.Heidelberg Engineering Inc. |
15.2.7.Docs Eye Care |
15.2.8.Optos |
15.2.9.Phoenix Technology Group, LLC |
15.2.10.Visunex Medical Systems, Inc. |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players